The nation’s largest pharmacy serving elder care facilities will pay Massachusetts nearly half a million dollars to settle allegations that it got kickbacks more than eight years ago from Abbott Laboratories to promote the anti-seizure drug, Depakote.
The settlement was signed by Omnicare, a pharmacy services company that was acquired by CVS Health Corporation (NYSE: CVS) in August 2015. The $476,216 payment to Massachusetts is part of a $28 million multi-state settlement.
According to a release, Omnicare solicited and received illegal payments from Abbott (NYSE: ABT) through agreements that required Omnicare to participate in certain promotional programs, grants and other financial support. Those agreements, intended to increase the use of Depakote, resulted in alleged false claims to Medicaid and other federally-funded health care programs from 2001 through 2008.
The settlement was based on two cases filed by whistleblowers in Virginia. Those cases were consolidated and are pending in the U.S. District Court for the Western District of Virginia. For the full article click here
from health IT caucus http://ift.tt/2eUtX4D
via IFTTT
No comments:
Post a Comment